TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage produc…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
TransCode Therapeutics, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
TransCode Therapeutics, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of TransCode Therapeutics, Inc..